11 Semaglutide Subscription Services I Actually Compared (And What Made Each One Different)

The providers below are being judged against the 2026 market, not last year’s assumptions. Pharmacy identity, cash price, and clinical follow-up matter more after the latest wave of regulatory and manufacturer pressure.

Here is what I found after going through eleven current options side by side.

1. HealthRX

Compounded semaglutide starts at $99 a month. Compounded tirzepatide starts at $149. Those are among the lowest cash prices I found anywhere in this category, and there are no contracts or hidden fees. The medication ships overnight to all 50 states at no added cost, which matters if you live somewhere rural or in a state that some smaller platforms skip.

What I found worth noting: the pharmacy is named. Medications are dispensed through Manifest Pharmacy in Greer, South Carolina, a 503A compounding facility that operates under USP-797 standards with lot tracking from production to delivery. That level of supply-chain transparency is not universal in this space. The platform also holds LegitScript certification (cert 50087439), and a board-certified physician reviews your intake within roughly 24 hours.

The clinical data HealthRX points to comes from the major trials: STEP 1 showed semaglutide averaging about 15% body weight reduction at 68 weeks; SURMOUNT-1 showed tirzepatide averaging about 21% at 72 weeks. These are trial figures, not platform-specific claims.

Best for: cash-pay patients who want a low entry price, named pharmacy sourcing, and fast nationwide shipping.

2. FormBlends

FormBlends sits at a higher price point than HealthRX ($299 per vial for semaglutide, $349 for tirzepatide), but it earns its slot here for a specific reason: published batch testing. The platform posts per-product purity results including HPLC purity percentages, mass spec identity confirmation, and endotoxin and sterility data. That is more documentation than most compounded GLP-1 providers make public.

It also carries peptides well beyond GLP-1s. Recovery, longevity, and cognitive compounds sit under the same physician-supervised model. If you want a single telehealth account covering GLP-1 treatment and, say, BPC-157 or other catalog peptides, FormBlends supports that. Ships to 47 states, not all 50.

Best for: patients who prioritize documented purity testing, or anyone who wants GLP-1 therapy and a broader peptide catalog from one provider and is comfortable paying a premium for it.

3. Mochi Health

Mochi uses board-certified obesity-medicine physicians, which is a meaningful distinction. The monitoring is more involved than what you get from pure prescription-relay services. Compounded semaglutide runs about $99 a month; compounded tirzepatide is around $199. Good price-to-oversight ratio.

4. Hims & Hers

After exiting compounded GLP-1 medications following the March 2026 Novo settlement, Hims & Hers now focuses on branded options. Injectable Wegovy is listed at roughly $299 a month, oral semaglutide at about $249, and Zepbound at around $399. With insurance and manufacturer savings cards, some patients pay $0 to $25. If you have insurance and want a brand-name medication, this path can get quite affordable. Cash-pay pricing is steep without that coverage.

5. Ro Body

Ro charges around $39 for the first month, then $74 to $149 per month ongoing. Medications bill separately. It has a prior-authorization team that works with insurers on branded prescriptions, which is genuinely useful if you have coverage and do not want to fight that process yourself.

6. PlushCare

Monthly membership is about $19.99. PlushCare focuses on branded medications and works with insurance. Same-day visits are available. The low membership fee makes it one of the more accessible entry points for someone who already has insurance coverage for a GLP-1.

7. Henry Meds

Cash-pay, compounded, and fast. Henry ships within 24 to 72 hours. First-month pricing runs roughly $179 to $249. Monitoring is lighter than Mochi or Calibrate, which suits some people and concerns others. Fine if you are already familiar with GLP-1 protocols and want straightforward access.

8. Eden

Compounded semaglutide at about $149 a month. Eden is a smaller, direct platform. It gets the job done without much frills. Not the cheapest, not the most monitored, somewhere in the middle of the market.

9. Found

Found charges roughly $99 a month for the platform and adds medication costs on top. Coaching is included. The combination of behavioral support and prescribing in one subscription appeals to people who want accountability alongside the medication.

10. Sesame

Annual membership starts around $59 a month. Medications are priced and billed separately. Sesame is more of a general telehealth marketplace with GLP-1 prescribing available rather than a dedicated weight-loss program. Worth considering if you want flexibility and already know what you are asking for.

11. MEDVi

Compounded GLP-1s, first-month pricing around $179, no contracts. MEDVi is straightforward and no-commitment. There is not a lot of public differentiation beyond that, but the no-lock-in structure matters to people who want to try without committing to a long program.

How to Actually Choose

Price alone is a poor filter. A $99 starting price from a pharmacy with named sourcing and lot tracking is different from a $99 price with no transparency about where the compound came from. Similarly, a $299 branded medication with insurance dropping it to $25 beats an uninsured $149 cash option for some people. HealthRX and Mochi are the strongest cash-pay picks at the entry level. FormBlends is the move if purity documentation matters more to you than price. Ro and PlushCare are better fits if you have real insurance coverage to work with.

Compounded GLP-1 medications are not FDA-approved products. They are legal under specific regulatory conditions, but those conditions have been actively shifting through 2025 and 2026. Check current regulatory status before subscribing to any compounding-based service.

Common Questions

Does the named pharmacy actually matter when choosing a compounded semaglutide subscription?

Yes, significantly. When a platform names its dispensing pharmacy, you can independently verify that the facility holds 503A status with the FDA, check for any warning letters, and confirm USP-797 compliance. Platforms that do not disclose their compounding source give you no way to perform that check yourself, which is a real gap in accountability.

If Hims & Hers dropped compounded semaglutide after the Novo settlement, what does that mean for patients already on it?

It means those patients had to transition to branded Wegovy, oral semaglutide, or Zepbound at significantly higher list prices, unless insurance covered the switch. The settlement’s effect was abrupt for some subscribers. Anyone choosing a platform now should ask directly whether their compounded product could be discontinued if regulatory conditions shift again.

What does FormBlends’ batch testing actually show, and why don’t other platforms publish the same data?

FormBlends posts HPLC purity percentages, mass spec identity confirmation, and endotoxin and sterility results per batch. Most platforms either do not pay for that testing or pay for it but do not publish results publicly. Publishing it costs nothing extra once the tests are done, so the absence elsewhere is more a transparency choice than a cost one.

Is there a meaningful clinical difference between semaglutide from HealthRX at $99 and Wegovy from Hims & Hers at $299?

Wegovy is the FDA-approved branded product with the full trial safety and efficacy record behind it. Compounded semaglutide from a 503A pharmacy uses the same active ingredient but is not FDA-approved as a finished drug product. The $99 option may work well for many people, but it carries regulatory and quality-assurance differences that are worth understanding before you choose.

Can you switch between these subscription services without losing your dosing history or starting a new titration from scratch?

Most platforms do not coordinate with each other, so your titration records stay with the original provider. You would typically need to transfer records manually or have a new prescriber review them. Some platforms, including Ro, have prior-authorization teams that can help bridge branded prescriptions, but compounded-to-branded or platform-to-platform switches generally require a fresh intake and physician review.

Sources

• FDA rules governing pharmacy compounding and 503A facility requirements, FDA.gov
• STEP 1 trial (semaglutide): Wilding et al., *New England Journal of Medicine*, 2021
• SURMOUNT-1 trial (tirzepatide): Jastreboff et al., *New England Journal of Medicine*, 2022
• Coverage of the Novo Nordisk legal settlement, Reuters and STAT News, March 2026
• LillyDirect orforglipron pricing, Eli Lilly press materials, April 2026
• LegitScript certification database, LegitScript.com